1Kaste M.Thrombolysis.What more does it take[J]? Stroke,2005,36:200-202.
2Arora S,Broderick JP,Frankel M,et al.Acute stroke care in the US:results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry[J].Stroke,2005,36:1232-1240.
3Calfornia Acute Stroke Pilot Registry (CASPR) Investigations.Prioritizing interventions to improve rates of thrombolysis for ischemic stroke[J].Neurology,2005,64:654-659.
4Cocho D,Belvis R,Marti-Fabregas J,et al.Reasons for exclusion from thrombolytic therapy following acute ischemic stroke[J].Neurology,2005,64:719-720.
5Katzan IL,Hammer MD,Hixon ED,et al.Utilization of intravenous tissue plasminogen activator for acute ischemic stroke[J].Arch Neurol,2004,61:346-350.
6Graham GD.Tissue plasminogen activator for acute ischemic stroke in clinical practice:a meta-analysis of safety data[J].Ann Neurol,2002,52(suppl 1):524.
7Ergin A,Ergin N.Is thrombolytic therapy associated with increased mortality? Meta-analysis of randomized controlled trials[J].Arch Neurol,2005,62:362-366.
8Hill MD,Buchan AM.Thrombolysis for acute ischemic stroke:results of the Canadian Alteplase for Stroke Effectiveness Study[J].CMAJ,2005,172:1307-1312.
9The IMS Study Investigators.Combined intravenous and intra-arterial recanalization for acute ischemic stroke:The Interventional Management of Stroke Study[J].Stroke,2004,35:904-911.
10Flaherty ML,Woo D,Kissela B,et al.Combined IV and intra-arterial thrombolysis for acute ischemic stroke[J].Neurology,2005,64:386-388.
